Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone

International high-risk clones of Klebsiella pneumoniae are among the most common nosocomial pathogens. Increased diversity of plasmid-encoded antimicrobial resistance genes facilitates spread of these clones causing significant therapeutic difficulties. The purpose of our study was to investigate f...

Full description

Bibliographic Details
Main Authors: Judit Domokos, Ivelina Damjanova, Katalin Kristof, Balazs Ligeti, Bela Kocsis, Dora Szabo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.00157/full
id doaj-5642764a1f1f406793758361e1140b85
record_format Article
spelling doaj-5642764a1f1f406793758361e1140b852020-11-25T02:18:37ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-02-011010.3389/fmicb.2019.00157341991Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 CloneJudit Domokos0Ivelina Damjanova1Katalin Kristof2Balazs Ligeti3Balazs Ligeti4Bela Kocsis5Dora Szabo6Institute of Medical Microbiology, Semmelweis University, Budapest, HungaryNational Public Health Institute, Budapest, HungaryInstitute of Laboratory Medicine, Clinical Microbiology Laboratory, Semmelweis University, Budapest, HungaryInstitute of Medical Microbiology, Semmelweis University, Budapest, HungaryFaculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, HungaryInstitute of Medical Microbiology, Semmelweis University, Budapest, HungaryInstitute of Medical Microbiology, Semmelweis University, Budapest, HungaryInternational high-risk clones of Klebsiella pneumoniae are among the most common nosocomial pathogens. Increased diversity of plasmid-encoded antimicrobial resistance genes facilitates spread of these clones causing significant therapeutic difficulties. The purpose of our study was to investigate fluoroquinolone resistance in extended-spectrum beta-lactamase (ESBL)-producing strains, including four K. pneumoniae and a single K. oxytoca, isolated from blood cultures in Hungary. Whole-genome sequencing and molecular typing including multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) were performed in selected strains. Gene expression of plasmid-mediated quinolone resistance determinants (PMQR) was investigated by quantitative-PCR. MLST revealed that three K. pneumoniae strains belonged to ST11 and one to ST307 whereas K. oxytoca belonged to ST52. The isolates harbored different β-lactamase genes, however, all K. pneumoniae uniformly carried blaCTX-M-15. The K. pneumoniae isolates exhibited resistance to fluoroquinolones and carried various PMQR genes namely, two ST11 strains harbored qnrB4, the ST307 strain harbored qnrB1 and all K. pneumoniae harbored oqxAB efflux pump. Levofloxacin and moxifloxacin MIC values of K. pneumoniae ST11 and ST307 clones correlated with qnr and oqxAB expression levels. The qnrA1 carrying K. oxytoca ST52 exhibited reduced susceptibility to fluoroquinolones. The maintained expression of qnr genes in parallel with chromosomal mutations indicate an additional protective role of Qnr proteins that can support dissemination of high-risk clones. During development of high-level fluoroquinolone resistance, high-risk clones retain fitness thus, enabling them for dissemination in hospital environment. Based on our knowledge this is the first report of ST307 clone in Hungary, that is emerging as a potential high-risk clone worldwide. High-level fluoroquinolone resistance in parallel with upregulated PMQR gene expression are linked to high-risk K. pneumoniae clones.https://www.frontiersin.org/article/10.3389/fmicb.2019.00157/fullinternational clonesmulti-drug resistancewhole genome sequence analysisgene expressionplasmid-mediated quinolone resistance
collection DOAJ
language English
format Article
sources DOAJ
author Judit Domokos
Ivelina Damjanova
Katalin Kristof
Balazs Ligeti
Balazs Ligeti
Bela Kocsis
Dora Szabo
spellingShingle Judit Domokos
Ivelina Damjanova
Katalin Kristof
Balazs Ligeti
Balazs Ligeti
Bela Kocsis
Dora Szabo
Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone
Frontiers in Microbiology
international clones
multi-drug resistance
whole genome sequence analysis
gene expression
plasmid-mediated quinolone resistance
author_facet Judit Domokos
Ivelina Damjanova
Katalin Kristof
Balazs Ligeti
Balazs Ligeti
Bela Kocsis
Dora Szabo
author_sort Judit Domokos
title Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone
title_short Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone
title_full Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone
title_fullStr Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone
title_full_unstemmed Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone
title_sort multiple benefits of plasmid-mediated quinolone resistance determinants in klebsiella pneumoniae st11 high-risk clone and recently emerging st307 clone
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2019-02-01
description International high-risk clones of Klebsiella pneumoniae are among the most common nosocomial pathogens. Increased diversity of plasmid-encoded antimicrobial resistance genes facilitates spread of these clones causing significant therapeutic difficulties. The purpose of our study was to investigate fluoroquinolone resistance in extended-spectrum beta-lactamase (ESBL)-producing strains, including four K. pneumoniae and a single K. oxytoca, isolated from blood cultures in Hungary. Whole-genome sequencing and molecular typing including multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) were performed in selected strains. Gene expression of plasmid-mediated quinolone resistance determinants (PMQR) was investigated by quantitative-PCR. MLST revealed that three K. pneumoniae strains belonged to ST11 and one to ST307 whereas K. oxytoca belonged to ST52. The isolates harbored different β-lactamase genes, however, all K. pneumoniae uniformly carried blaCTX-M-15. The K. pneumoniae isolates exhibited resistance to fluoroquinolones and carried various PMQR genes namely, two ST11 strains harbored qnrB4, the ST307 strain harbored qnrB1 and all K. pneumoniae harbored oqxAB efflux pump. Levofloxacin and moxifloxacin MIC values of K. pneumoniae ST11 and ST307 clones correlated with qnr and oqxAB expression levels. The qnrA1 carrying K. oxytoca ST52 exhibited reduced susceptibility to fluoroquinolones. The maintained expression of qnr genes in parallel with chromosomal mutations indicate an additional protective role of Qnr proteins that can support dissemination of high-risk clones. During development of high-level fluoroquinolone resistance, high-risk clones retain fitness thus, enabling them for dissemination in hospital environment. Based on our knowledge this is the first report of ST307 clone in Hungary, that is emerging as a potential high-risk clone worldwide. High-level fluoroquinolone resistance in parallel with upregulated PMQR gene expression are linked to high-risk K. pneumoniae clones.
topic international clones
multi-drug resistance
whole genome sequence analysis
gene expression
plasmid-mediated quinolone resistance
url https://www.frontiersin.org/article/10.3389/fmicb.2019.00157/full
work_keys_str_mv AT juditdomokos multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
AT ivelinadamjanova multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
AT katalinkristof multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
AT balazsligeti multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
AT balazsligeti multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
AT belakocsis multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
AT doraszabo multiplebenefitsofplasmidmediatedquinoloneresistancedeterminantsinklebsiellapneumoniaest11highriskcloneandrecentlyemergingst307clone
_version_ 1724880912162750464